Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Calliditas Therapeutics A...

    NASDAQ: CALT · Real-Time Price · USD
    40.00
    -0.04 (-0.10%)
    At close: Sep 20, 2024, 10:00 PM

    Calliditas Therapeutics AB (publ) Income Statement

    Financials in SEK. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 1.21B 802.88M 229.35M
    Cost of Revenue
    		 77.06M 15.2M n/a
    Gross Profit
    		 1.13B 787.68M 229.35M
    Operating Income
    		 -384.4M -421.94M -524.46M
    Interest Income
    		 29.09M 50.2M 102K
    Pretax Income
    		 -457.02M -409.42M -513.37M
    Net Income
    		 -466.19M -412.27M -509.54M
    Selling & General & Admin
    		 1.06B 774.66M 390.23M
    Research & Development
    		 499.54M 414.75M 357.49M
    Other Expenses
    		 n/a 20.21M 6.08M
    Operating Expenses
    		 1.51B 1.21B 753.8M
    Interest Expense
    		 73.2M 12.53M 7.11M
    Selling & Marketing Expenses
    		 727.74M 515.19M 179.6M
    Cost & Expenses
    		 1.59B 1.22B 753.8M
    Income Tax Expense
    		 9.17M 2.85M -3.84M
    Shares Outstanding (Basic)
    		 26.84M 26.51M 12.93M
    Shares Outstanding (Diluted)
    		 26.84M 26.51M 12.99M
    EPS (Basic)
    		 -17.38 -15.56 -39.42
    EPS (Diluted)
    		 -17.38 -15.56 -39.24
    EBITDA
    		 -367.8M -388.82M -483.94M
    EBIT
    		 -383.82M -376.62M -506.26M
    Depreciation & Amortization
    		 16.59M 12.91M 34.43M

    Add to Watchlist